Ritu Roy
Impact in
- Ophthalmology top 0.5%
- Ocular Oncology and Treatments
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer Genomics and Diagnostics 11
-
- Cancer-related cognitive impairment studies 3
- Co-authors
- Boris C. Bastian (5 shared papers)Klaus Johannes BUSAM (2 shared papers)Joan M. O’Brien (1 shared paper)Klaus Griewank (1 shared paper)Michael R. Speicher (1 shared paper)Thomas Wiesner (1 shared paper)Igor Dolgalev (1 shared paper)Raya Khanin (1 shared paper)
- Journals
- Nature Communications (6 papers)Cancer Research (4 papers)Epigenetics (3 papers)Supportive Care in Cancer (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Ritu Roy
74 papers receiving 4.1k citations
Ritu Roy's Hit Papers
Peers
Comparison fields: 5 of 126
- Ophthalmology 785
- Cancer Research 674
- Oncology 1.2k
- Molecular Biology 1.8k
- Immunology 432
Countries citing papers authored by Ritu Roy
This map shows the geographic impact of Ritu Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritu Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritu Roy more than expected).
Fields of papers citing papers by Ritu Roy
This network shows the impact of papers produced by Ritu Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritu Roy. The network helps show where Ritu Roy may publish in the future.
Co-authors
The 25 scholars most cited alongside Ritu Roy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutations in GNA11 in Uveal Melanoma Hit paper breakdown → | 2010 | 1202 |
| 2 | 2015 | 222 | |
| 3 | 2017 | 214 | |
| 4 | 2019 | 150 | |
| 5 | 2010 | 131 | |
| 6 | 2017 | 126 | |
| 7 | 2018 | 117 | |
| 8 | 2009 | 112 | |
| 9 | 2020 | 101 | |
| 10 | 2011 | 96 | |
| 11 | 2008 | 89 | |
| 12 | 2009 | 88 | |
| 13 | 2012 | 83 | |
| 14 | 2018 | 79 | |
| 15 | 2012 | 69 | |
| 16 | 2017 | 60 | |
| 17 | 2013 | 59 | |
| 18 | 2012 | 58 | |
| 19 | 2011 | 58 | |
| 20 | 2009 | 57 |
About Ritu Roy
Ritu Roy is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Genetics, having authored 75 papers that have together received 4.2k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (13 papers), Cancer Genomics and Diagnostics (11 papers), Genomic variations and chromosomal abnormalities (5 papers), Acute Lymphoblastic Leukemia research (5 papers), RNA modifications and cancer (4 papers), Cancer Cells and Metastasis (4 papers), Glioma Diagnosis and Treatment (4 papers) and Cancer-related cognitive impairment studies (3 papers). The work is most often cited by research in Ophthalmology (785 citations), Cancer Research (674 citations), Oncology (1.2k citations), Molecular Biology (1.8k citations) and Immunology (432 citations). Ritu Roy has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Boris C. Bastian, Klaus Johannes BUSAM, Joan M. O’Brien, Klaus Griewank, Michael R. Speicher, Thomas Wiesner, Igor Dolgalev, Raya Khanin, Anna C. Obenauf and Michelle B. Crosby. Their work appears in journals such as Nature Communications, Cancer Research, Epigenetics, Supportive Care in Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.